baber/WOPTO huggingface dataset:
Patent CA-2964048-A1 (CA)
Inventor: SEILER ANDREAS
IPC: B22C9/12
Filed: 2015-11-20
Abstract: The invention relates to a device (1) for reprocessing and cooling foundry sand, comprising a mixing container (2) and a mixing tool that can be rotated about a drive shaft (4), wherein an air feed (7) is provided for feeding air into the container interior. The problem addressed by the invention is that of providing an improved device by means of which a more uniform fluidized bed is achieved, preferably over the entire cross-section of the mixing container, wherein furthermore the proportion of the solid particles entrained by the gas flow should be reduced. This problem is solved, according to the invention, in that the mixing tool has at least two mixing vanes (8) spaced apart from each other in the vertical direction and at least one mixing vane has a mixing blade having a surface that is angled with respect to the horizontal.
Patent CA-2969652-A1 (CA)
Title: Improved mto process for enhanced production of propylene and high value products
Inventor: CHELLPPANNAIR THULASIDAS
IPC: C07C11/04
Filed: 2015-12-03
Abstract: A process is presented for the production of light olefins. The process utilizes a SAPO-18 catalyst and is operated at an elevated pressure. The process generates higher concentrations of heavier olefins which can then be processed to generate light olefins. The processing of the heavier olefins can include metathesis reactions and olefin cracking processes.
Patent CA-2971949-A1 (CA)
Inventor: CHEDEAU CHRISTOPHER SERGE BENJAMIN
IPC: H04L12/16
Filed: 2014-03-11
Abstract: In particular embodiments, a computing device determines a social context of each of one or more images to provide for display to a user. The computing device determines a relevance of each of the social contexts to the user. The computing device provides for display to the user one or more of the images based at least in part on the relevance of the social context of each image to the user.
Patent CA-2974453-A1 (CA)
Title: Anticorps anti-cd3, anticorps anti-cd123 et anticorps bispecifiques se liant specifiquement a cd3 et/ou cd123
Inventor: ALBRECHT JANA
IPC: C12N15/13
Filed: 2016-01-22
Abstract: La présente invention concerne une protéine de liaison de type anticorps se liant spécifiquement à CD3 et se liant de façon spécifique à au moins un autre antigène, par exemple CD123. La présente invention concerne également une protéine de liaison de type anticorps se liant spécifiquement à CD123 et se liant de façon spécifique à au moins un autre antigène. L'invention concerne en outre des anticorps anti-CD3 et des anticorps anti-CD123. L'invention concerne également des compositions pharmaceutiques comprenant la protéine de liaison de type anticorps, les anticorps anti-CD3 ou les anticorps anti-CD123 de l'invention, et leur utilisation pour traiter le cancer. L'invention concerne également des acides nucléiques isolés, des vecteurs et des cellules hôtes comprenant une séquence codant pour ladite protéine de liaison de type anticorps, un anticorps anti-CD3 ou anti-CD123 et l'utilisation dudit anticorps anti-CD123 comme outil de diagnostic.
Patent CA-2975489-A1 (CA)
Inventor: CHEN MINGHAN
IPC: G02C7/04
Filed: 2017-08-04
Abstract: A soft contact lens designed to improve visual performance with reduced pupil edge wavefront aberration, reduced halo and reduced light scattering. The soft contact lens is designed with pupil apodization for modulating the lens amplitude transmission profile.
Patent CA-2978174-A1 (CA)
Inventor: ROUSSEAU CEDRIC
IPC: A61K8/02
Filed: 2016-02-25
Abstract: The present disclosure relates to an infusion product for making a beverage, such as a tea or tea-like drink. In order to produce the composition of the present disclosure, plant materials are contacted with a solvent to remove an extract. The remaining plant materials are then formed into a fibrous structure or network, such as a sheet or fibrous layer. The extract may be further treated or concentrated and then reapplied to the plant materials. In accordance with the present disclosure, the resulting sheet or layer is then reduced to discrete pieces having a unique particle size distribution. Through the process of the present disclosure, a composition is produced that not only has a minimal amount of fines and dust, but can also have a relatively low bulk density.
Patent CA-2979228-A1 (CA)
Inventor: CROWDER ASHLEY
IPC: G03H1/22
Filed: 2016-03-11
Abstract: La présente invention concerne des systèmes et des procédés se rapportant à un système interactif holographique de vente au détail. En particulier, dans divers modes de réalisation, une image holographique (par exemple, illusion du fantôme de Pepper) est utilisée dans un établissement de vente au détail (par exemple, une vitrine d'un magasin) et, lorsqu'elle est combinée avec une commande par gestes, permet à des personnes de s'approcher du système et de rechercher et d'acheter des produits. Par exemple, les clients peuvent interagir avec un vendeur holographique et peuvent sélectionner des produits holographiques via une commande par gestes. Un achat final peut être effectué par le biais du dispositif mobile du client ou par le biais d'un kiosque libre-service, expédiant le produit au domicile du client.
Patent CA-2980012-A1 (CA)
Inventor: BAI MINGZHUO
IPC: C22C38/14
Filed: 2015-09-16
Abstract: Un acier pour pipeline X80 présentant de bonnes performances de vieillissement après déformation comprend (en % en poids) : C : 0,02 à 0,05 % ; Mn : 1,30 à 1,70 % ; Ni : 0,35 à 0,60 % ; Ti : 0,005 à 0,020 % ; Nb : 0,06 à 0,09 % ; Si : 0,10 à 0,30 % ; Al : 0,01 à 0,04 % ; N = 0,008 % ; P = 0,012 % ; S = 0,006 % ; Ca : 0,001 à 0,003 %, le reste étant du fer et les inévitables impuretés.
Patent CA-2980660-A1 (CA)
Title: Biotine pour le traitement de la sclerose laterale amyotrophique
Inventor: SEDEL FREDERIC
IPC: A61K31/4188
Filed: 2016-03-25
Abstract: L'invention concerne l'utilisation de la biotine pour le traitement de la sclérose latérale amyotrophique, ainsi que des neuropathies périphériques démyélinisantes et la neuromyélite optique (NMO).
Patent CA-2981561-A1 (CA)
Title: Flow reducing implant
Inventor: BEN MUVHAR SHMUEL
IPC: A61B17/00
Filed: 2002-10-03
Abstract: A flow reducing implant which includes a flared section adapted to contact a blood vessel wall. The flow reducing implant also includes at least one narrowed section continuous with the flared section. The implant is defined by a sheet material with slots and wherein a width of the slots varies over the implant to control a geometry of the implant.
Patent CA-2984077-A1 (CA)
Title: Appareil et procede permettant de reproduire un signal audio multicanal
Inventor: HEIL CHRISTIAN
IPC: H04R5/02
Filed: 2016-04-28
Abstract: L'invention concerne un procédé de production d'un signal audio multicanal à partir d'un ou de plusieurs signaux d'objet sonore, selon lequel on produit pour chaque signal d'objet sonore une pluralité de signaux de largeur, l'amplitude des signaux de largeur suivant une distribution sensiblement gaussienne. Les signaux de largeur sont traités pour produire une pluralité de signaux panoramiques qui sont mis en correspondance avec au moins un canal. Chaque canal dans le signal audio est produit en combinant les signaux panoramiques provenant de chaque objet sonore. L'invention concerne également un appareil (10) permettant de reproduire ledit signal audio multicanal, lequel comporte une pluralité de premiers haut-parleurs (12) agencés espacés autour d'un premier arc (14) en avant d'une zone d'écoute prédéterminée (16), chacun des premiers haut-parleurs (12) étant tourné vers la zone d'écoute (16) et sensiblement à égale distance de cette dernière Plusieurs seconds haut-parleurs (18) sont agencés espacés autour d'un second arc (20) derrière la zone d'écoute (16), chacun des seconds haut-parleurs (18) étant tourné vers la zone d'écoute (16). Un amplificateur (28) produit un signal amplifié à partir de chaque canal dans le signal audio, et chaque signal amplifié est délivré à un premier ou à un second haut-parleur correspondant (12, 18), chaque objet sonore étant reproduit en cours d'utilisation par le ou les haut-parleurs (12, 18) de telle manière que le niveau de pression sonore (SPL) est moins élevé en un point éloigné de l'appareil (10) qu'au niveau de la zone d'écoute (16).
Patent CA-2985908-A1 (CA)
Inventor: CIRPUS PETRA
IPC: A01H5/10
Filed: 2007-02-21
Abstract: The invention relates to a method for producing eicosapentanoic acid, docosapentanoic acid and/or docohexanoic acid in transgenic plants. According to said method, the plant is provided with at least one nucleic acid sequence coding for a polypeptide with a .DELTA.6 desaturase activity, at least one nucleic acid sequence coding for a polypeptide with a .DELTA.6 elongase activity, at least one nucleic acid sequence coding for a polypeptide with a .DELTA.5 desaturase activity, and at least one nucleic acid sequence coding for a polypeptide with a .DELTA.5 elongase activity, the nucleic acid sequence coding for a polypeptide with a .DELTA.5 elongase activity being modified in relation to the nucleic acid sequence in the organism from which the sequence originates, such that it is adapted to the codon use in at least one type of plant. For the production of docosahexanoic acid, at least one nucleic acid sequence coding for a polypeptide with a .DELTA.4 desaturase activity is also introduced into the plant.
Patent CA-2986379-A1 (CA)
Title: Circulated tumor cell biomaked and therapeutic target
Inventor: CHERESH DAVID A
IPC: G01N33/577
Filed: 2016-04-20
Abstract: Provided are compositions and methods comprising use of beta-3 integrin for detecting circulating tumor cells (CTCs), tumor stem cells, extracellular vesicles (EVs), including exosomes and microvesicles, that are released by CTCs or cancer cells, and the tumor from which the CTCs or EVs derive, to make a patient prognosis, and to assess tumor progression, and drug resistance, e.g., for breast, colon, lung and pancreatic cancers. In alternative embodiments, a patient fluid sample, e.g., blood, is taken and used to detect cancer stem cells, EVs- and/or CTCs-comprising beta-3 integrin and/or alphavbeta3 integrin. Provided are compositions and methods using biomarker beta-3 integrin for anti-cancer drug design; and compositions and methods that include conjugation of an imaging or therapeutic agent to an antibody targeting integrin ß3 for detection and/or targeted destruction of integrin beta-3 expressing cancer stem cells and/or CTCs.
Patent CA-2987178-A1 (CA)
Inventor: GOYETTE LISE M
IPC: A61F7/08
Filed: 2017-11-30
Abstract: A reusable moist radiant heat collar pack for muscle pain, tension and relaxation. Allows moist deep heat to permeate and penetrate into the sternocleidomastoideus (neck muscle), trapezius (upper back muscle), pectoralis major (upper chest muscle) and splenius capitis (lower rear head/neck muscle) using radiant heat performing pain relief and relaxation simultaneously and making manipulation therapy (massage) more effective.
Patent CA-2987878-A1 (CA)
Inventor: BROWN JODI LEE
IPC: B65D83/20
Filed: 2016-06-01
Abstract: La présente invention concerne un produit de laque aérosol comprenant un récipient qui comporte une paroi de récipient entourant un réservoir. Le réservoir comprend entre environ 40 % et environ 70 % d'une formulation de laque et entre environ 30 % et environ 60 % d'un propulseur diméthyléther. La formulation de laque comprend de l'eau, un ou plusieurs polymères de coiffage, et entre environ 0,05 % et environ 2 % d'alcool. Un dispositif de pulvérisation est fixé au récipient. Le dispositif de pulvérisation comprend une soupape comportant un logement de soupape qui comprend un robinet de vapeur incluant une zone de robinet de vapeur. Un tube plongeur est relié à la soupape. Le tube plongeur comprend un orifice de tube plongeur incluant une zone d'orifice de tube plongeur. Le rapport entre la zone de robinet de vapeur et la zone d'orifice de tube plongeur est d'environ 0,005 à environ 0,15.
Patent CA-2989139-A1 (CA)
Inventor: CHATANI HIROSHI
IPC: C07K7/06
Filed: 2008-12-05
Abstract: This invention is intended to be used to search for a transcription factor having novel functions of increasing the weight of an individual plant, increasing the weight of a given tissue per individual plant, or improving the productivity of a given substance per individual plant and to improve such properties in the plant. The weight of an individual plant is increased, the weight of a given tissue per individual plant is increased, the productivity of a given substance per individual plant is improved, or the content of a given substance per given tissue of a plant is increased via expression of a transcription factor that has been modified to suppress transcription accelerating activity.
Patent CA-2991249-A1 (CA)
Title: Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
Inventor: CARGILL MICHELE
IPC: G01N33/68
Filed: 2004-11-24
Abstract: A method is provided for indicating whether a human has an increased risk for a myocardial infarction (MI), or whether a human's risk for MI is reduced by treatment with an HMG-CoA reductase inhibitor, e.g. a statin such as pravastatin, atorvastatin, simvastatin, cerevastatin, or lovastatin. The method comprises testing nucleic acid from the human for presence or absence of a single nucleotide polymorphism at position 101 of SEQ  ID NO:200 or its complement. Presence of G at position 101 of SEQ ID NO:200 or C at position 101 of the complement indicates that the human has increased risk for MI and that the risk is reduced by such treatment. Also provided are polynucleotides useful for such testing.
Patent CA-2999209-A1 (CA)
Title: Homeoproteins for use in the treatment of neurodegenerative disorders
Inventor: PROCHIANTZ ALAIN
IPC: A61P25/00
Filed: 2016-09-23
Abstract: The present invention relates to the use of a homeoprotein or a recombinant vector encoding said protein for treating or preventing DNA damage and/or cellular aging. In particular, the invention concerns the use of Engrailed for the treatment of Parkinson disease.
Patent CA-3003080-A1 (CA)
Inventor: HAMPSON CARL
IPC: C08K5/101
Filed: 2016-10-26
Abstract: The present invention relates to an assembly of matter comprising mineral fibers, synthetic fibers or natural fibers, cellulosic particle or sheet material, bonded together by a curable binder composition comprising a monosaccharide and/or polysaccharide and an azetidinium crosslinker and possibly reaction product resulting from the cross-linking between polysaccharide and azetidinium crosslinker, or by a binder obtained by subjecting to curing conditions an aqueous curable binder composition comprising a monosaccharide and/or polysaccharide and an azetidinium crosslinker and possibly reaction product resulting from the cross-linking between polysaccharide and azetidinium crosslinker.The binder composition may further comprise a crosslinkercapable of undergoing radical polymerization. Binder compositions and a process for manufacturing said assembly of matter are also disclosed..
Patent CA-3007960-A1 (CA)
Inventor: McDonald David Arlen
IPC: B67D1/02
Filed: 2016-05-04
Abstract: The embodiment relates to the dispensing of beer from a fluid reservoir, providing a portion of the beer as foam atop it. To avoid the reduction of absorbed carbon dioxide in dispensed beer, a fluid control mechanism provides increased atmospheric pressure to dispense the beer from the reservoir. A temperature-control means is in fluid communication with the beer. An oscillator, coupled with a voltage controller, is associated with the fluid control mechanism and in fluid communication with the beer. Control of the voltage to the oscillator and control of the fluid control mechanism supports a method for dispensing the beer according to a recipe for beverage temperature, proportion of liquid beverage to foam and density of the foam. A non-transitory machine-readable storage medium designed to recognize the properties of beer in a beer-container and to provide an associated recipe for dispensing the beer.
Patent CA-3009249-A1 (CA)
Title: Wind turbine blades and potential equalization systems
Inventor: NIELSEN LARS
IPC: F03D80/30
Filed: 2016-12-19
Abstract: The present disclosure relates to a wind turbine blade comprising a load carrying structure, a shell body and a lightning protection system. The wind turbine blade extends in a longitudinal direction between a root end and a tip end. The load carrying structure is made of a fibre-reinforced polymer material and comprises a plurality of stacked fibre layers. The stacked fibre layers comprise electrically conductive fibres, such as carbon fibres. The lightning protection system comprises a lightning receptor arranged freely accessible in or on the shell body. The lightning protection system comprises a lightning down-conductor, which is electrically connected to the lightning receptor and is further configured to be electrically connected to a ground connection. The wind turbine blade further comprises a potential equalisation system, which provides a potential equalising connection between a number of the electrically conductive fibres of the load carrying structure and the lightning protection system. The potential equalisation system comprises a dissipating element made of an electrically conductive material. The dissipating element comprises at least one transverse connector that is arranged so as to extend transverse through a thickness of the stacked fibre layers and configured to dissipate.
Patent CA-3012751-A1 (CA)
Title: Method of locating a fault in a power transmission scheme
Inventor: HA HENGXU
IPC: G01R31/08
Filed: 2017-02-02
Abstract: There is provided a method of locating a fault in a power transmission scheme. The power transmission scheme includes a plurality of power transmission sections and a plurality of connection points (J0-J5), the plurality of connection points includes a first end connection point (J0), a second end connection point (J5)and at least one intermediate connection point (J1-J4), and each of the plurality of power transmission sections is arranged to interconnect a respective two of the plurality of connection points such that the plurality of power transmission sections are connected successively between the first and second end connection points and such that the or each intermediate connection point interconnects (J1-J4) a or a respective neighbouring pair of the power transmission sections. The method comprises the steps of: (i) measuring first and second end voltage phasors at the first and second end connection points (J0, J5) respectively; (ii) obtaining a first set of voltage phasors, wherein the first set of voltage phasors includes the measured first end voltage phasor and further includes respective voltage phasors at each of the second and intermediate connection points that are determined based on the measured first end voltage phasor; (iii) obtaining a second set of voltage phasors, wherein the second set of voltage phasors includes the measured second end voltage phasor and further includes respective voltage phasors at each of the first and intermediate connection points that are determined based on the measured second end voltage phasor; (iv) comparing the first and second sets of voltage phasors to identify the power transmission section or connection point corresponding to the location of the fault, wherein each voltage phasor of the first set of voltage phasors is compared to the respective voltage phasor of the second set of voltage phasors that corresponds to the same connection point.
Patent CA-3018080-A1 (CA)
Inventor: DIOP SEYDOU
IPC: F16G11/04
Filed: 2017-03-15
Abstract: A cable splice includes a casing having a central portion and a first end including a first aperture. The casing defines an interior cavity. A guide assembly extends through the first opening into the interior cavity. A first clamp member is positioned in the interior cavity and moveable between a loading position and a terminated position. A first biasing member biases the first clamp member toward the terminated position. A carrier is positioned in the interior cavity between the first biasing member and the central region. A second clamp member is positioned in the carrier and moveable with respect to the carrier.
Patent CA-3018636-A1 (CA)
Inventor: BELLMANN GUNTHER
IPC: A61K9/00
Filed: 2017-04-12
Abstract: The present invention relates to a drop-forming, storage stable, multiphase, ophthalmic composition comprising at least one liquid aqueous phase and at least one liquid hydrophobic phase, characterized in that it is emulsifier-free as well as buffer-free and comprises hyaluronic acid and/or hyaluronate.
Patent CA-3018872-A1 (CA)
Title: Methodes de traitement et de prevention d'une infection a c. difficile
Inventor: TANAKA S KEN
IPC: A61K31/65
Filed: 2017-03-24
Abstract: L'invention concerne des méthodes de traitement ou de prévention d'une infection à C. difficile et des états pathologiques associés liés à une infection à C. difficile.
Patent CA-3019237-A1 (CA)
Title: Method and device for transdermally applying electrical stimulation to a region of the head having high impedance
Inventor: BELSON RON
IPC: A61N1/00
Filed: 2017-04-09
Abstract: A method and apparatus for transdermally providing electrical current to a region of a user's head at high impedance conditions, while maintaining low voltage levels.
Patent CA-3020197-A1 (CA)
Inventor: SHEWALE JAIPRAKASH G
IPC: A61K8/44
Filed: 2018-09-03
Abstract: Some embodiments described herein provide for a multi-component compositions and methods for its pharmaceutical and cosmetic use, comprising a combination of an aliphatic anionic compound, an oxidative compound, and a buffering system. Source of fluoride ion and other carriers are optional ingredients. The aliphatic anionic compound and the oxidative compound function together, in presence or absence of fluoride ion source, to protect the oxidative compounds from degradation prior to use and upon use, and to enhance the efficacy of the composition. In addition to achieving greater stability, combined effects of the aliphatic anionic compound, oxidative compound and source of fluoride ion achieve enhanced fluoride uptake, higher enamel protection by enhanced remineralization and reduced demineralization, increased plaque removal, reduced re-growth of plaque polymicrobial biofilm, greater amount of chlorite ion availability and effective oxidation of salivary biomolecules.
Patent CA-3022504-A1 (CA)
Title: Systeme de mesure d'angle de rotation optique
Inventor: GUGGENMOS MARKUS
IPC: G01D5/38
Filed: 2017-05-03
Abstract: La présente invention concerne un système optique pour mesurer l'angle de rotation d'un objet rotatif ayant un arbre de rotation (2), lequel système comprend un élément de diffraction réfléchissant (6) monté sur ledit arbre et un module qui comporte une source de rayonnement (8) émettant un faisceau monochromatique (bo) vers ledit élément et une structure de détection sensible à un rayonnement (14, 16). L'élément de diffraction est configuré pour projeter des images d'ordre de diffraction (18) de son motif sur des sections associées (50(1)-54(2)) d'une structure de réseau annulaire faisant partie de la structure de détection, et la taille de surface de l'élément de diffraction est inférieure à 20 % de la taille de surface de la structure de réseau annulaire.
Patent CA-3026863-A1 (CA)
Inventor: KRONTHALER ULRICH
IPC: C07K14/505
Filed: 2017-07-12
Abstract: The present invention relates to a method or process of producing a glycoprotein that interacts with, or acts as an agonist to, the erythropoietin receptor (EpoR), which glycoprotein has modified efficacy, wherein the method or process comprises the heterologous expression of said glycoprotein in a suitable expression system, and wherein at least one step is provided that results in a reduced acetylation rate of sialic acid residues in the glycoprotein (Fig. 16).